Part of clients' anxiety about this issue stems from the uncertainty of how much or how long such health care expenses will be incurred.

Guardant Health has secured Medicare coverage from Palmetto for its blood test to monitor for disease recurrence in patients with colorectal cancer.

The General Enrollment Period provides an opportunity to make up for a past oversight – the failure to enroll in Part B.

An executive order designed to lower the cost of prescription drugs was one of the measures rescinded by President Donald ...

An advocacy group aligned with Democrats will launch a $10 million “Hands Off Medicaid” campaign that highlights how the ...

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...

The rescinded orders include directives boosting the Affordable Care Act exchanges, coordinating the government’s COVID-19 ...

NEW YORK – Guardant Health announced Tuesday that its Guardant Reveal liquid biopsy test has received coverage from Medicare administrative contractor Palmetto GBA to monitor colorectal cancer ...

Older Australians, particularly retirees or those on lower incomes, were more likely to select hospital insurance based on ...

Hospitals are also seeing higher uncompensated care as individuals lose Medicaid coverage or decide not to purchase health insurance. If there are changes to the health insurance exchanges, more ...

Medicare Advantage isn’t that great an advantage for seniors compared with traditional Medicare, researchers say.The ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...